MAOA and glioblastoma: Since MAO-A and heat shock protein 90 (HSP90) inhibitors have proven their effectiveness against glioblastoma progression, a recent study reported the development of MAO-A/HSP90 dual inhibitors based on isopropylresorcinol and clorgyline.